MIMS (Malaysia) drug information results matching Xarelto
User Information
NEWS | CME 
 Linagliptin lowers blood sugar in type 2 diabetics   Researchers in Asia point to better sepsis treatments   Asian lung cancer vaccine trial resumes after temporary hold   Type 1 Diabetes Mellitus in Children and Adolescents   Coronary CT predicts future cardiac events   Recommendations for the Management of Neuropathic Pain Associated With Peripheral Nerve Entrapment   Non-HDL Cholesterol: When and how to Treat   Gefitinib improves progression-free survival in NSCLC with EGFR mutations   The JUPITER trial: Do the results apply to Asians?   Women's heart attacks differ from men's   Chinese women largely unaware of heart disease and stroke risk   Conflicting Recommendations for Lipid Screening and Management in Children: The Need for Consensus   7th International Symposium on Respiratory Diseases (ISRD)   Ethnicity is a strong indicator of cardiovascular risk   Community-based lifestyle intervention beneficial in Chinese diabetes, hypertension patients   
MIMS Info PubMed
Results 1-1 of 1 for Xarelto (0 seconds)
Other(s): China  HK  India  Indonesia  Malaysia  Phil  S'pore  Taiwan  Thai  US  Vietnam  ALL  
Display: Brief  Full      Search in: Drug Only  All  
Xarelto film-coated tab® [ Bayer Schering Pharma ]  [ Zuellig Pharma ] - rivaroxaban
Indication: Prevention of VTE in adults undergoing elective hip or knee replacement therapy.
MIMS Class: Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics) 
Interaction  Search PubMed  

 
  
 
China MIMS Online Home Page Hong Kong MIMS Online Home Page India MIMS Online Home Page Indonesia MIMS Online Home Page Malaysia MIMS Online Home Page Philippines MIMS Online Home Page Singapore MIMS Online Home Page Taiwan MIMS Online Home Page Thailand MIMS Online Home Page Vietnam MIMS Online Home Page